Related Experiment Video
Updated: Nov 15, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
COVID-19 fatality rates in hospitalized patients: systematic review and meta-analysis
Ana Macedo1, Nilza Gonçalves2, Cláudia Febra3
1Keypoint - Consultoria Científica, Lda, Lisbon, Portugal; Departamento de Ciências Biomédicas e Medicina, Universidade do Algarve, Faro, Portugal.
Insights
This study evaluated coronavirus disease (COVID-19) mortality rates, finding an overall 17.1% fatality. Critical care patients faced a significantly higher mortality rate of 40.5%.
Area of Science:
- Epidemiology
- Infectious Diseases
- Public Health
Background:
- Coronavirus disease (COVID-19) is a novel infectious disease.
- Accurate mortality rates for COVID-19 were largely unknown.
- This study aimed to determine COVID-19 case fatality rates.
Purpose of the Study:
- To evaluate the mortality of COVID-19 patients.
- To provide data for resource allocation and economic impact assessments.
Main Methods:
- Systematic literature search of PubMed and EMBASE databases.
- Inclusion of studies on clinical characteristics and outcomes of COVID-19 patients.
- Independent article selection by two authors.
Main Results:
- A total of 33 studies comprising 13,398 COVID-19 patients were analyzed.
- The overall COVID-19 mortality rate was 17.1%.
- Mortality rates were 11.5% for general hospital admissions and 40.5% for critical care cases.
Conclusions:
- High mortality rates in COVID-19 patients necessitate careful resource allocation.
- Understanding COVID-19 fatality is crucial for economic burden calculations during pandemics.
Background:
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. Although general and local public health report deathly cases, case fatality rates are still largely unknown. Thus, we sought to evaluate the mortality of COVID-19.
Methods:
We searched PubMed and EMBASE databases for articles evaluating the clinical characteristics of COVID-19 patients that included clinical outcomes, between December 2020 and 24 April 2020. Two authors performed an independent selection using predefined terms of search.
Results:
We retrieved 33 studies with a total of 13,398 patients with COVID-19 diagnosis. The mortality rate of the COVID-19 patients was 17.1% (95% CI 12.7; 22.7, I2 = 96.9%). For general patients admitted to the hospital (excluding critical care-only studies) the mortality rate of the COVID-19 was 11.5% (95% CI 7.7; 16.9, I2 = 96.7%). Among critical illness studies (n = 7) we found a 40.5% mortality (95% CI 31.2; 50.6, I2 = 91.8%).
Conclusion:
High COVID-19 mortality among general admitted patients and critical care cases should guide resources allocations and economic burden calculations during the pandemics.
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Hazard Rate
Bias in Epidemiological Studies

